PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 2 filers reported holding PTC THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,246 | -87.4% | 2,376 | -77.1% | 0.00% | -85.7% |
Q2 2023 | $421,301 | +221637.4% | 10,359 | +164.1% | 0.01% | +133.3% |
Q1 2023 | $190 | +143.6% | 3,922 | +92.2% | 0.01% | +100.0% |
Q4 2022 | $78 | -100.0% | 2,041 | -92.9% | 0.00% | -87.0% |
Q3 2022 | $1,438,000 | +63.0% | 28,635 | +30.2% | 0.02% | +15.0% |
Q2 2022 | $882,000 | +237.9% | 22,000 | +213.5% | 0.02% | +900.0% |
Q1 2022 | $261,000 | -39.6% | 7,018 | -35.3% | 0.00% | -71.4% |
Q4 2021 | $432,000 | +99.1% | 10,842 | +86.4% | 0.01% | +16.7% |
Q3 2021 | $217,000 | -15.9% | 5,815 | -4.7% | 0.01% | -14.3% |
Q2 2021 | $258,000 | -28.1% | 6,100 | -19.6% | 0.01% | +16.7% |
Q1 2021 | $359,000 | +136.2% | 7,586 | +205.5% | 0.01% | +20.0% |
Q4 2020 | $152,000 | +46.2% | 2,483 | +11.3% | 0.01% | +400.0% |
Q3 2020 | $104,000 | -71.4% | 2,230 | -68.9% | 0.00% | -93.3% |
Q2 2020 | $364,000 | +18100.0% | 7,169 | +18282.1% | 0.02% | – |
Q4 2019 | $2,000 | -98.5% | 39 | -99.0% | 0.00% | -100.0% |
Q3 2019 | $130,000 | +80.6% | 3,843 | +82.5% | 0.01% | +80.0% |
Q4 2018 | $72,000 | +380.0% | 2,106 | +376.5% | 0.01% | +400.0% |
Q2 2018 | $15,000 | -92.5% | 442 | -94.0% | 0.00% | -94.1% |
Q1 2018 | $199,000 | +729.2% | 7,356 | +420.6% | 0.02% | +466.7% |
Q4 2017 | $24,000 | +118.2% | 1,413 | +155.1% | 0.00% | +200.0% |
Q3 2017 | $11,000 | -81.7% | 554 | -89.9% | 0.00% | -85.7% |
Q4 2016 | $60,000 | +900.0% | 5,510 | +512.2% | 0.01% | +600.0% |
Q2 2016 | $6,000 | +500.0% | 900 | +350.0% | 0.00% | – |
Q1 2016 | $1,000 | -96.4% | 200 | -76.9% | 0.00% | -100.0% |
Q4 2015 | $28,000 | -58.2% | 867 | -37.5% | 0.01% | -16.7% |
Q2 2015 | $67,000 | -40.2% | 1,387 | -24.5% | 0.01% | -57.1% |
Q1 2015 | $112,000 | +11100.0% | 1,836 | +4862.2% | 0.01% | – |
Q2 2014 | $1,000 | -85.7% | 37 | -90.8% | 0.00% | -100.0% |
Q4 2013 | $7,000 | -65.0% | 400 | -57.3% | 0.00% | -50.0% |
Q3 2013 | $20,000 | – | 937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |